Compare RENT & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RENT | LENZ |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.6M | 106.8M |
| IPO Year | 2021 | 2021 |
| Metric | RENT | LENZ |
|---|---|---|
| Price | $2.31 | $3.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $23.86 |
| AVG Volume (30 Days) | 138.3K | ★ 744.4K |
| Earning Date | 12-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 110.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $329,800,000.00 | $19,088,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $152.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.71 | N/A |
| 52 Week Low | $1.51 | $3.12 |
| 52 Week High | $10.13 | $32.92 |
| Indicator | RENT | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 60.55 | 32.50 |
| Support Level | $1.51 | N/A |
| Resistance Level | $3.91 | $6.11 |
| Average True Range (ATR) | 0.16 | 0.21 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 97.59 | 13.89 |
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe to, or buy designer apparel and accessories. The company gives customers access to its unlimited closet through its subscription offering (Subscription) or the ability to rent a-la-carte through its reserve offering (Reserve). The company also gives its subscribers and customers the ability to buy its products through its Resale offering. The Closet in the Cloud offers a wide assortment of items for every occasion, from evening wear and accessories to ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear, and ski wear.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.